Amrutanjan Health Care Limited (BOM:590006)
India
· Delayed Price · Currency is INR 558.90
+0.30 (0.05%)
At close: Mar 9, 2026
Amrutanjan Health Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 16,158 | 18,643 | 17,886 | 16,806 | 23,203 | 16,610 | Upgrade
|
| Market Cap Growth | -8.74% | 4.23% | 6.42% | -27.57% | 39.69% | 72.22% | Upgrade
|
| Enterprise Value | 14,103 | 16,371 | 15,843 | 14,821 | 21,224 | 15,209 | Upgrade
|
| Last Close Price | 558.90 | 640.72 | 610.78 | 563.49 | 772.95 | 550.09 | Upgrade
|
| PE Ratio | 28.40 | 36.67 | 39.77 | 42.19 | 34.53 | 27.15 | Upgrade
|
| Forward PE | - | 25.99 | 25.99 | 25.99 | 25.99 | 25.99 | Upgrade
|
| PS Ratio | 3.31 | 4.13 | 4.25 | 4.43 | 5.72 | 4.99 | Upgrade
|
| PB Ratio | 4.72 | 5.71 | 6.20 | 5.78 | 8.75 | 7.71 | Upgrade
|
| P/TBV Ratio | 4.75 | 5.74 | 6.25 | 5.83 | 8.83 | 7.76 | Upgrade
|
| P/FCF Ratio | - | 121.48 | 84.39 | 149.33 | 80.76 | 18.68 | Upgrade
|
| P/OCF Ratio | - | 36.63 | 64.08 | 83.28 | 44.45 | 18.28 | Upgrade
|
| PEG Ratio | - | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | Upgrade
|
| EV/Sales Ratio | 2.89 | 3.62 | 3.76 | 3.90 | 5.23 | 4.57 | Upgrade
|
| EV/EBITDA Ratio | 20.44 | 28.00 | 30.45 | 32.32 | 25.56 | 20.35 | Upgrade
|
| EV/EBIT Ratio | 22.35 | 30.74 | 33.53 | 35.41 | 26.58 | 21.18 | Upgrade
|
| EV/FCF Ratio | - | 106.68 | 74.76 | 131.70 | 73.87 | 17.11 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Debt / FCF Ratio | - | 0.14 | 0.08 | 0.08 | 0.03 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.60 | -0.59 | -0.71 | -0.62 | -0.75 | -0.81 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.99 | -3.30 | -3.95 | -3.96 | -2.41 | -2.33 | Upgrade
|
| Net Debt / FCF Ratio | - | -12.59 | -9.69 | -16.13 | -6.97 | -1.96 | Upgrade
|
| Asset Turnover | - | 1.15 | 1.16 | 1.07 | 1.30 | 1.39 | Upgrade
|
| Inventory Turnover | - | 8.15 | 7.52 | 6.84 | 8.46 | 6.95 | Upgrade
|
| Quick Ratio | - | 2.97 | 3.65 | 3.52 | 3.09 | 3.70 | Upgrade
|
| Current Ratio | - | 3.44 | 4.23 | 4.13 | 3.55 | 4.28 | Upgrade
|
| Return on Equity (ROE) | - | 16.53% | 15.53% | 14.33% | 27.96% | 32.64% | Upgrade
|
| Return on Assets (ROA) | - | 8.45% | 8.10% | 7.35% | 15.99% | 18.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 33.83% | 36.18% | 35.68% | 35.70% | 111.22% | 73.36% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 15.80% | 15.90% | 14.00% | 29.30% | 32.30% | Upgrade
|
| Earnings Yield | 3.52% | 2.73% | 2.51% | 2.37% | 2.90% | 3.68% | Upgrade
|
| FCF Yield | - | 0.82% | 1.19% | 0.67% | 1.24% | 5.35% | Upgrade
|
| Dividend Yield | 0.82% | 0.72% | 0.75% | 0.82% | 0.60% | 0.76% | Upgrade
|
| Payout Ratio | 23.37% | 26.10% | 29.77% | 36.17% | 18.57% | 9.45% | Upgrade
|
| Buyback Yield / Dilution | 0.12% | 0.38% | 0.71% | 0.03% | -0.00% | -0.02% | Upgrade
|
| Total Shareholder Return | 0.95% | 1.09% | 1.46% | 0.85% | 0.59% | 0.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.